These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 11705835)
1. Do statins reduce the risk for diabetes by improving exercise capacity? Ur E; Shlossberg A Circulation; 2001 Nov; 104(20):E104-5. PubMed ID: 11705835 [No Abstract] [Full Text] [Related]
3. [Pravastatin and the development of diabetes mellitus. Evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study]. Comaschi MA; Menozzi F Ital Heart J Suppl; 2001 May; 2(5):556-8. PubMed ID: 11388336 [No Abstract] [Full Text] [Related]
4. Statins for high-risk patients without heart disease or high cholesterol. Med Lett Drugs Ther; 2006 Jan; 48(1225):1-3. PubMed ID: 16374400 [No Abstract] [Full Text] [Related]
5. Effect of pravastatin in people with diabetes and chronic kidney disease. Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin. Lee TM; Lin MS; Chang NC Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772 [TBL] [Abstract][Full Text] [Related]
12. [Statin treatment in type 2 diabetes. Is it a must today?]. Faust M MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527 [No Abstract] [Full Text] [Related]
13. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation. Mahle WT; Vincent RN; Berg AM; Kanter KR J Heart Lung Transplant; 2005 Jan; 24(1):63-6. PubMed ID: 15653381 [TBL] [Abstract][Full Text] [Related]
14. Exercise, statins, and stroke prevention in Type 2 diabetes. Mascitelli L; Pezzetta F Diabet Med; 2008 Mar; 25(3):375. PubMed ID: 18307465 [No Abstract] [Full Text] [Related]
15. Statins and renal function. Is the compound and dose making a difference? Athyros VG; Karagiannis A; Kakafika A; Elisaf M; Mikhailidis DP Nephrol Dial Transplant; 2007 Mar; 22(3):963-4; author reply 964. PubMed ID: 17255130 [No Abstract] [Full Text] [Related]
16. Treating low HDL-cholesterol in normocholesterolaemic patients with coronary disease: statins, fibrates or horses for courses? Watts GF Eur Heart J; 2004 May; 25(9):716-9. PubMed ID: 15120879 [No Abstract] [Full Text] [Related]
17. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly]. MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640 [No Abstract] [Full Text] [Related]
18. Cardiovascular health in New Zealand: areas of concern and targets for improvement in 2008 and beyond. Ellis CJ; Hamer AW N Z Med J; 2008 Feb; 121(1269):5-10. PubMed ID: 18278077 [No Abstract] [Full Text] [Related]
19. Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease. Corte TJ; Wort SJ Clin Sci (Lond); 2009 Mar; 116(6):493-5. PubMed ID: 19037879 [TBL] [Abstract][Full Text] [Related]
20. Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Tonelli M; Isles C; Curhan GC; Tonkin A; Pfeffer MA; Shepherd J; Sacks FM; Furberg C; Cobbe SM; Simes J; Craven T; West M Circulation; 2004 Sep; 110(12):1557-63. PubMed ID: 15364796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]